Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2002-11-27
2009-08-11
Lin, Jerry (Department: 1631)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C702S019000
Reexamination Certificate
active
07572590
ABSTRACT:
Method for early differential diagnosis and detection, prognosis and assessment of the severity and therapy-accompanying assessment of the course of sepsis and sepsis-like systemic infections, in which, preferably with determination of at least one further parameter suitable for sepsis diagnosis, the amount of CA 19-9 in a biological fluid of a patient who is suffering from sepsis or is suspected of having sepsis is determined and conclusions are drawn from the determined amount of CA 19-9 with regard to the presence, the expected course, the severity and/or the success of initiated measures for the treatment of the sepsis.
REFERENCES:
patent: 5639617 (1997-06-01), Bohuon
patent: 5660994 (1997-08-01), Bruder-Heid et al.
patent: 198 47 690 (2000-04-01), None
patent: 101 19 804 (2002-10-01), None
patent: 101 30 985 (2003-01-01), None
patent: 101 31 922 (2003-01-01), None
patent: 1 318 404 (2004-07-01), None
patent: WO 00/22439 (2000-04-01), None
patent: WO 02/085937 (2002-10-01), None
patent: WO 03/002600 (2003-01-01), None
patent: WO 03/005035 (2003-01-01), None
Aird, “The Hematologic System as a Marker of Organ Dysfunction in Sepsis,”Mayo Clin, Proc., 78:869-881, 2003.
Assicot, et al., “High Serum Procalcitonin Concentrations in Patients with Sepsis and Infection,”Lancet, 341(8844):515-518, 1993.
Beishuizen et al., “Endogenous Mediators in Sepsis and Septic Shock,”Advances Clin. Chem., 33:55-131, 1999.
Carrigan et al., “Toward Resolving the Challenges of Sepsis Diagnosis,”Clin. Chem., 50(8):1301-1314, 2004.
Gabay and Kushner, “Acute-Phase Proteins and Other Systemic Responses to Inflammation,”New Engl. J. Med., 340(6):448-454, 1999.
Hotchkiss and Karl, “The Pathophysiology and Treatment of Sepsis,”N. Engl. J. Med., 348(2):138-150, 2003.
Karzai, et al., “Procalcitonin—A New Indicator of the Systemic Response to Severe Infections,”Infection, 25:3-8, 1997.
Ker et al., “Assessment of Serum and Bile Levels of CA19-9 and CA125 in Cholangitis and Bile Duct Carcinoma,”J. Gastro. Hepta., 6:505-508, 1991.
Lab Tests Online, CA 19-9, Internet document, last modified Jun. 26, 2002.
Lamerz, “CA 19-9, GICA (Gastrointestinal Cancer Antigen)” Labor and Diagnose, Section 34.3, 5thEdition, Ed. Lother Thomas, TH-Books Verlagsgesellschaft, 1998, p. 966-969.
Marshall et al., “Measures, Markers, and Mediators: Toward a Staging System for Clinical Sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, Oct. 25-26, 2000,”Crit. Care Med., 31(5):1560-1567, 2003 (Abstract only).
Oberholzer et al., “Sepsis Syndromes: Understanding the Role of Innate and Acquired Immunity,”Shock, 16(2):83-96, 2001 (Abstract only).
Oczenski et al., “Procalcitonin: A New Parameter for the Diagnosis of Bacterial Infection in the Peri-Operative Period,”Eur. J. Anaesthesiol., 15:202-209, 1998.
Pfister et al., “Elevated Carbohydrate Antigen 19-9 (CA 19-9) in Patients with Echinococcus Infection,”Clin. Chem. Lab Med., 39(6):527-530, 2001.
Redl et al., “Procalcitonin Release Patterns in a Baboon Model of Trauma and Sepsis: Relationship to Cytokines and Neopterin,”Crit. Care Med., 28(11):3659-3663, 2000.
Redl and Schlag, “Non-Human Primate Models of Sepsis,”Sepsis, 2:243-253, 1998.
Reinhart et al., “Sepsis Und Spetischer Schcok,”Intensivmedizin, 756-760, 2001.
International Search Report for EPO Application No. 01128850.3, mailed Jun. 4, 2002.
International Search Report for PCT Application No. PCT/EP 02/13392, mailed Mar. 11, 2003.
B.R.A.H.M.S. Aktiengesellschaft
Heslin Rothernberg Farley & Mesiti P.C.
Lin Jerry
LandOfFree
Method for the diagnosis of sepsis with determination of CA... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the diagnosis of sepsis with determination of CA..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the diagnosis of sepsis with determination of CA... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4081766